MO's alliance with KT&G aims to accelerate its global push into modern oral nicotine and smoke-free products.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Altria Group, Inc. reported mixed Q3 results, missing revenue expectations but delivering in-line EPS, leading to a 5% price pullback. MO's strategic partnerships and expansion of its smokeless tobacco portfolio, including On! PLUS and LOOP, position it for future growth amid cigarette volume declines. Lower base rates and recent partnerships are expected to provide tailwinds and accelerate MO's growth.
MO's oral tobacco unit hits a 69% margin in the third quarter, powered by pricing discipline and cost control despite volume declines.
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Altria Group's stock price fell at a double-digit rate, presenting me and you with a "buy the dip" opportunity. The market overreacted to some negative news presented in Altria's Q3 2025 statements concerning both smokeable and non-smokeable segments. Investors should keep a long-term orientation when it comes to Altria's key initiatives on its path to smoke-free portfolio.
Shares of Altria Group Inc. ( NYSE: MO ) plummeted 14.25% over the past month after losing 1.47% the month prior.
MO's Helix unit drives margin gains as new on! PLUS nicotine pouches launch in key states amid tough pricing pressure.
Altria (MO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here is how Altria (MO) and Ambev (ABEV) have performed compared to their sector so far this year.
Altria Group, Inc. reported a solid Q3 2025 with adjusted EPS up 5% and strong free cash flow. MO stock nevertheless dropped 7% in reaction to the report. MO's core cigarette business remains highly profitable, with margin expansion and continued dominance in the premium segment, but faces retail share pressure from downtrading. Disappointing Q3 performance in the oral nicotine segment, especially on! pouches, raises concerns.
Altria Group, Inc. ( MO ) Q3 2025 Earnings Call October 30, 2025 9:00 AM EDT Company Participants Mac Livingston - Vice President of Investor Relations William Gifford - CEO & Director Salvatore Mancuso - Executive VP & CFO Conference Call Participants Matthew Smith - Stifel, Nicolaus & Company, Incorporated, Research Division Bonnie Herzog - Goldman Sachs Group, Inc., Research Division Eric Serotta - Morgan Stanley, Research Division Mirza Faham Baig - UBS Investment Bank, Research Division Presentation Operator Good day, and welcome to the Altria Group 2025 Third Quarter and 9 Months Earnings Conference Call. Today's call is scheduled to last about 1 hour, including remarks by Altria's management and a question-and-answer session.